A deal which could generate immense health benefits in Africa was signed earlier this year by two major pharmaceutical companies, Cipla and Pfizer, working with the American Cancer Society.
It means that six African countries will save more than 50% of the current cost of cancer medicines.
Those six are Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.
Dr Megan O’Brien, from the American cancer society, is the chief organiser of the deal.
She told BBC Newsday that they chose those six countries because that’s where the deal will have the most impact.Please subscribe to our newsletter